Intervention Protocol

Bromocriptine for type 2 diabetes mellitus

  1. Cheow Peng Ooi1,*,
  2. Seng Cheong Loke2

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 31 JAN 2013

DOI: 10.1002/14651858.CD010319

How to Cite

Ooi CP, Loke SC. Bromocriptine for type 2 diabetes mellitus (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD010319. DOI: 10.1002/14651858.CD010319.

Author Information

  1. 1

    Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Endocrine Unit, Department of Medicine, Serdang, Selangor DE, Malaysia

  2. 2

    Universiti Putra Malaysia, Institute of Gerontology, Serdang, Selangor DE, Malaysia

*Cheow Peng Ooi, Endocrine Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor DE, 43400, Malaysia. cpooi07@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 31 JAN 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of bromocriptine for type 2 diabetes mellitus.